SNAI2 and hepatocellular carcinoma: Furthermore,in vitroandin vivo analyses demonstrate that TMEM106A knockdown promotes HCC progression by inducting EMT through the Erk1/2/Slug signaling pathway which may serve as a potential therapeutic target.